Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use LANTUS safely and effectively. See full prescribing information for LANTUS. LANTUS® (insulin glargine) injection, for subcutaneous use Initial U.S. Approval: 2000
Medication labelWhy this: Advisory · dailymed-prescription
LANTUS is indicated to improve glycemic control in adult and pediatric patients with diabetes mellitus. Limitations of Use LANTUS is not recommended for the treatment of diabetic ketoacidosis.
- generic_name
- insulin glargine
- product_names
- insulin glargine
- ndc
- 50090-0876, 0088-2220, 50090-0876-0
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en